KCNN4 and sickle cell disease: KCNN4 gain-of-function mutations cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (18–21), and KCa3.1 inhibition attenuates some indices of disease severity in murine (22, 23) and human sickle cell disease (24).